Global /India /Healthcare /Drug Manufacturers - General /SENORES

Senores Pharmaceuticals Ltd.

SENORES

• NSE: SENORES • Delayed

899.20INR -0.5%

9.39 USD

As of 5 June 2026, Senores Pharmaceuticals Ltd. has a market cap of $434.56M USD, ranking #16121 globally and #865 in India. It ranks #1449 in the Healthcare sector, and #526 in the Drug Manufacturers - General industry.

Global Rank

16121

Country Rank

865

Sector Rank

1449

Industry Rank

526

Key Stats

Market Cap

$434.56MUSD

41.61B INR

Enterprise Value

$440.72MUSD

42.2B INR

Revenue (TTM)

$57.8MUSD

5.53B INR

EBITDA (TTM)

$15.68MUSD

1.5B INR

Net Income (TTM)

$10.61MUSD

1.02B INR

EBITDA Margin

27%

Profit Margin

18%

PE Ratio

40.3

Forward PE

31.3

PS Ratio

7.5

PB Ratio

5.0

EV/EBITDA

27.8

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Swapnil Shah open_in_new

Employees

194

Founded

2017

Website

senorespharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.5%	0.9%	15%	14%	15%	9.9%	76%	72%	72%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	SENORES Senores Pharmaceuticals Ltd ISIN: INE0RB801010 Shares Out.: Shares Outstanding: 46.054M¹ Shares Float: 21.095M² TV: TradingView: NSE: SENORES SA: Stock Analysis: NSE: SENORES YF: Yahoo Finance: SENORES.NS GF: Google Finance: NSE: SENORES BA: Barron's: SENORES MS: Morningstar: XNSE: SENORES	899.20 INR	TV: TradingView: NSE: SENORES SA: Stock Analysis: NSE: SENORES YF: Yahoo Finance: SENORES.NS GF: Google Finance: NSE: SENORES BA: Barron's: SENORES MS: Morningstar: XNSE: SENORES
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	544319 (SENORES) Senores Pharmaceuticals Ltd ISIN: INE0RB801010 TV: TradingView: BSE: SENORES SA: Stock Analysis: BOM: 544319 YF: Yahoo Finance: 544319.BO GF: Google Finance: BOM: 544319 BA: Barron's: 544319 MS: Morningstar: XBOM: 544319	900.15 INR	TV: TradingView: BSE: SENORES SA: Stock Analysis: BOM: 544319 YF: Yahoo Finance: 544319.BO GF: Google Finance: BOM: 544319 BA: Barron's: 544319 MS: Morningstar: XBOM: 544319

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.57B 4.27T INR 10K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.12B 1.73T INR 4K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$14.95B 1.43T INR 3K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.57B 1.11T INR 3K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.73B 931.67B INR 2K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.57B 916.53B INR 2K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 175K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 126K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 83K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 75K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 67K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 64K%	20.5	Switzerland

chevron_leftBack